Oxford/AstraZeneca jab less effective against South Africa variant, research finds
Related news coverage
In the coming months, vaccine nationalism is likely to compound COVID-19 economic damage and penalize more lives. It reflects the..
News24.com | Covid-19: Phase 1 of vaccine rollout plan will continue with Johnson & Johnson - Mkhize
South Africa's vaccine rollout will commence with Johnson & Johnson after the Oxford/AstraZeneca vaccine was found to be less..